In the current study, we studied the molecular mechanisms for the anticancer activities of DHA in glioma cells and implicated miR-21 and RECK as a target for therapeutic intervention in DHA-induced cancer cell death and invasion. This evidence concerns the gene RECK and central nervous system cancer.